Aminolevulinic Acid 20% Topical Solution with Blue Light (dose 10 J/cm2) for carcinoma, squamous cell

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Nov 2025: Trial started, NCT07931664
  2. 12 Nov 2026: Trial registered, NCT07931664

The trials

NCT07931664: Evaluating Photodynamic Therapy Used to Treat Cutaneous Squamous Cell Carcinoma in Situ (isSCC) on the Face, Upper Extremities & Trunk.

State
Under way
Phase
Phase 2
People
30 planned
Started
25 Nov 2025
Primary completion
Nov 2026
Arms
Facial isSCC Photodynamic Therapy (Blue light dose 10 J/cm2), Trunk and/or upper extremities isSCC Photodynamic Therapy (Blue light dose 10 J/cm2)
Results
None posted
  1. 25 Nov 2025: Trial started
  2. 12 Nov 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.